George A Eldridge is of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 5,022 shares of AVTE, which is worth approximately $13,157. The most recent transaction as insider was on Nov 30, 2022, when has been sold 85 shares (Common Stock) at a price of $2.14 per share, resulting in proceeds of $181. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.02K
0% 3M change
156.22% 12M change
Total Value Held $13,157

George A Eldridge Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2022
BUY
Exercise of conversion of derivative security
$181 $2.14 p/Share
85 Added 3.99%
2,045 Common Stock
Nov 23 2022
SELL
Open market or private sale
$24,047 $19.07 p/Share
1,261 Reduced 39.15%
1,960 Common Stock
Nov 23 2022
BUY
Exercise of conversion of derivative security
$2,698 $2.14 p/Share
1,261 Added 28.13%
3,221 Common Stock
Nov 22 2022
SELL
Open market or private sale
$3,307 $19.01 p/Share
174 Reduced 8.15%
1,960 Common Stock
Nov 22 2022
BUY
Exercise of conversion of derivative security
$372 $2.14 p/Share
174 Added 7.54%
2,134 Common Stock
Nov 21 2022
SELL
Open market or private sale
$38 $19.0 p/Share
2 Reduced 0.1%
1,960 Common Stock
Nov 21 2022
BUY
Exercise of conversion of derivative security
$4 $2.14 p/Share
2 Added 0.1%
1,962 Common Stock
Nov 18 2022
SELL
Open market or private sale
$17,039 $19.79 p/Share
861 Reduced 30.52%
1,960 Common Stock
Nov 18 2022
BUY
Exercise of conversion of derivative security
$1,842 $2.14 p/Share
861 Added 23.38%
2,821 Common Stock
GAE

George A Eldridge

Boston, MA

Track Institutional and Insider Activities on AVTE

Follow Aerovate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

News

Receive news related to Aerovate Therapeutics, Inc.

Track Activities on AVTE